Volume 58, Issue 5 pp. 819-822
Brief Report

Reduced bone mineral density in adult patients with Langerhans cell histiocytosis

Polyzois Makras MD, PhD

Corresponding Author

Polyzois Makras MD, PhD

Department of Endocrinology and Diabetes, 251 Hellenic Air Force & VA General Hospital, Athens, Greece

Department of Endocrinology & Diabetes, 251 Hellenic Air Force & VA General Hospital, 3 Kanellopoulou St., 115 25, Goudi, Athens.===Search for more papers by this author
Evangelos Terpos MD, PhD

Evangelos Terpos MD, PhD

Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece

Search for more papers by this author
George Kanakis MD

George Kanakis MD

Department of Pathophysiology, University of Athens School of Medicine, Athens, Greece

Search for more papers by this author
Athanasios Papatheodorou PhD

Athanasios Papatheodorou PhD

Department of Medical Research, 251 Hellenic Air Force and VA General Hospital, Athens, Greece

Search for more papers by this author
Athanasios D. Anastasilakis MD, PhD

Athanasios D. Anastasilakis MD, PhD

Department of Endocrinology, 424 Military Hospital, Thessaloniki, Greece

Search for more papers by this author
Panagiotis Kokkoris MD

Panagiotis Kokkoris MD

Department of Endocrinology and Diabetes, 251 Hellenic Air Force & VA General Hospital, Athens, Greece

Department of Medical Research, 251 Hellenic Air Force and VA General Hospital, Athens, Greece

Search for more papers by this author
Gregory A. Kaltsas MD, FRCP

Gregory A. Kaltsas MD, FRCP

Department of Pathophysiology, University of Athens School of Medicine, Athens, Greece

Search for more papers by this author
First published: 05 May 2011
Citations: 13

Conflict of interest: Nothing to declare.

Abstract

This retrospective study evaluated bone mineral density (BMD) and bone turnover in adults with LCH. Twenty-five adult patients and 25 matched controls were evaluated with BMD measurement and indices of bone metabolism. A BMD value below the expected range for age (Z-score ≤ − 2.0) was found in 20% of patients; in particular, all postmenopausal women and men over 50-years had either osteoporosis or osteopenia. Patients with active disease had significantly lower Z-scores compared to patients with inactive disease and controls. Reduced bone turnover was found in all 14 patients treated with chemotherapy. No fractures due to osteoporosis were identified during 305.15 patient-years of follow-up. Pediatr Blood Cancer 2012; 58: 819–822. © 2011 Wiley Periodicals, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.